Neurocrine Bioscience buy Barclays PLC
Start price
02.05.24
/
50%
€131.25
Target price
02.05.25
€157.54
Performance (%)
-0.27%
Price
17.05.24
€130.90
Summary
This prediction is currently active. Since the start of the prediction for Neurocrine Bioscience the price has only changed by -0.27%. This prediction currently runs until 02.05.25. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Neurocrine Bioscience | 3.152% |
iShares Core DAX® | -0.383% |
iShares Nasdaq 100 | 1.248% |
iShares Nikkei 225® | 0.525% |
iShares S&P 500 | 0.640% |
Comments by Barclays_PLC for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its price target raised by analysts at Barclays PLC from $150.00 to $169.00. They now have an "overweight" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Barclays_PLC for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€129.15
23.01.24
23.01.24
€137.96
23.01.25
23.01.25
1.36%
17.05.24
17.05.24